Literature DB >> 22035297

Doubling the referral rate of monogenic diabetes through a nationwide information campaign--update on glucokinase gene mutations in a Polish cohort.

M Borowiec1, W Fendler, K Antosik, A Baranowska, P Gnys, A Zmyslowska, M Malecki, W Mlynarski.   

Abstract

In order to improve recruitment efficiency of patients with monogenic diabetes in Poland, in September 2010 a nationwide advertising campaign was launched to inform multiple target groups interested or participating in pediatric diabetologic care. Promotional actions aimed at informing physicians, patients, parents and educators were carried out through nationwide newspapers, medical and patient-developed websites and educational conference presentations. Recruitment efficiency was compared between September 2010 (publication of the first report on project's results) and the following 12 months. The number of families and patients referred to genetic screening was increased by 92% and 96% respectively nearly reaching the numbers recruited throughout the initial 4 years of the project. Participation of non-academic centers was also significantly increased from 2.3% to 7.5% (p = 0.0005). DNA sequencing and Multiplex Ligation-dependant Probe Amplification of the glucokinase gene resulted in finding 50 different mutations. Among those mutations, 19 were novel variants, which included: 17 missense mutations (predicted to be pathogenic according to bioinformatic analysis), 1 nonsense mutation and 1 mutation affecting a consensus intronic splice site. Advertising actions directed at increasing recruitment efficiency are a powerful and possibly neglected tool in screening for rare genetic disorders with a clinically defined phenotype.
© 2011 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22035297     DOI: 10.1111/j.1399-0004.2011.01803.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  6 in total

1.  Identification of Variants Responsible for Monogenic Forms of Diabetes in Brazil.

Authors:  Gabriella de Medeiros Abreu; Roberta Magalhães Tarantino; Ana Carolina Proença da Fonseca; Juliana Rosa Ferreira de Oliveira Andrade; Ritiele Bastos de Souza; Camila de Almeida Pereira Dias Soares; Amanda Cambraia; Pedro Hernan Cabello; Melanie Rodacki; Lenita Zajdenverg; Verônica Marques Zembrzuski; Mário Campos Junior
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

Review 2.  Undiagnosed MODY: Time for Action.

Authors:  Jeffrey W Kleinberger; Toni I Pollin
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

3.  Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors.

Authors:  Wojciech Fendler; Joanna Madzio; Kamil Kozinski; Kashyap Patel; Justyna Janikiewicz; Magdalena Szopa; Adam Tracz; Maciej Borowiec; Przemyslawa Jarosz-Chobot; Malgorzata Mysliwiec; Agnieszka Szadkowska; Andrew T Hattersley; Sian Ellard; Maciej T Malecki; Agnieszka Dobrzyn; Wojciech Mlynarski
Journal:  Diabetologia       Date:  2016-04-08       Impact factor: 10.122

4.  Whole‑exome sequencing in Russian children with non‑type 1 diabetes mellitus reveals a wide spectrum of genetic variants in MODY‑related and unrelated genes.

Authors:  Oleg S Glotov; Elena A Serebryakova; Mariia E Turkunova; Olga A Efimova; Andrey S Glotov; Yury A Barbitoff; Yulia A Nasykhova; Alexander V Predeus; Dmitrii E Polev; Mikhail A Fedyakov; Irina V Polyakova; Tatyana E Ivashchenko; Natalia Y Shved; Elena S Shabanova; Alena V Tiselko; Olga V Romanova; Andrey M Sarana; Anna A Pendina; Sergey G Scherbak; Ekaterina V Musina; Anastasiia V Petrovskaia-Kaminskaia; Liubov R Lonishin; Liliya V Ditkovskaya; Liudmila А Zhelenina; Ludmila V Tyrtova; Olga S Berseneva; Rostislav K Skitchenko; Evgenii N Suspitsin; Elena B Bashnina; Vladislav S Baranov
Journal:  Mol Med Rep       Date:  2019-10-16       Impact factor: 2.952

5.  Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.

Authors:  Wojciech Fendler; Manfredi Rizzo; Maciej Borowiec; Beata Malachowska; Karolina Antosik; Agnieszka Szadkowska; Maciej Banach; Malgorzata Urbanska-Kosinska; Magdalena Szopa; Maciej Malecki; Wojciech Mlynarski
Journal:  Acta Diabetol       Date:  2014-02-19       Impact factor: 4.280

6.  GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey.

Authors:  Belma Haliloglu; Gerald Hysenaj; Zeynep Atay; Tulay Guran; Saygın Abalı; Serap Turan; Abdullah Bereket; Sian Ellard
Journal:  Clin Endocrinol (Oxf)       Date:  2016-07-05       Impact factor: 3.478

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.